APPLIED DNA SCIENCES INC's ticker is APDN and the CUSIP is 03815U201. A total of 31 filers reported holding APPLIED DNA SCIENCES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $9,000 | -55.0% | 40,695 | 0.0% | 0.00% | – |
| Q2 2019 | $20,000 | -31.0% | 40,695 | 0.0% | 0.00% | – |
| Q1 2019 | $29,000 | +81.2% | 40,695 | 0.0% | 0.00% | – |
| Q4 2018 | $16,000 | -73.8% | 40,695 | 0.0% | 0.00% | – |
| Q3 2018 | $61,000 | +19.6% | 40,695 | 0.0% | 0.00% | – |
| Q2 2018 | $51,000 | -13.6% | 40,695 | 0.0% | 0.00% | – |
| Q1 2018 | $59,000 | -9.2% | 40,695 | 0.0% | 0.00% | – |
| Q4 2017 | $65,000 | -42.0% | 40,695 | +4.5% | 0.00% | – |
| Q3 2017 | $112,000 | +62.3% | 38,924 | 0.0% | 0.00% | – |
| Q2 2017 | $69,000 | +7.8% | 38,924 | 0.0% | 0.00% | – |
| Q1 2017 | $64,000 | +1.6% | 38,924 | +14.4% | 0.00% | – |
| Q4 2016 | $63,000 | -37.6% | 34,039 | +2.9% | 0.00% | – |
| Q3 2016 | $101,000 | -5.6% | 33,086 | 0.0% | 0.00% | – |
| Q2 2016 | $107,000 | -6.1% | 33,086 | 0.0% | 0.00% | – |
| Q1 2016 | $114,000 | +6.5% | 33,086 | 0.0% | 0.00% | – |
| Q4 2015 | $107,000 | +1.9% | 33,086 | +61.9% | 0.00% | – |
| Q3 2015 | $105,000 | – | 20,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHASE INVESTMENT COUNSEL CORP | 261,163 | $186,000 | 0.10% |
| Laurel Wealth Advisors, Inc. | 100,000 | $71,000 | 0.02% |
| Quadrant Private Wealth Management, LLC | 20,000 | $14,000 | 0.01% |
| BREWIN DOLPHIN LTD | 80,565 | $57,403 | 0.01% |
| REILLY FINANCIAL ADVISORS, LLC | 50,000 | $36,000 | 0.01% |
| Sequoia Financial Advisors, LLC | 10,000 | $7,000 | 0.00% |
| IHT Wealth Management, LLC | 10,954 | $8,000 | 0.00% |
| TAURUS ASSET MANAGEMENT, LLC | 10,000 | $7,000 | 0.00% |
| MYCIO WEALTH PARTNERS, LLC | 25,000 | $18,000 | 0.00% |
| Onex Canada Asset Management Inc. | 20,000 | $14,000 | 0.00% |